ERIS LIFESCIENCES
|
The Current P/E Ratio of ERIS LIFESCIENCES is 57.04.
Share Price | ₹1,476.7 | Feb 07,2025 |
Market Cap | ₹20,097.9 Cr | |
Earnings-TTM | ₹352.3 Cr | TTM-Consolidated Results |
Price/Earnings | 57.04x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ERIS LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹20,097.9 Cr] as on Feb 07,2025
(/) Earnings [ ₹352.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 57.04x ]
Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay 57.04 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ERIS LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ERIS LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of ERIS LIFESCIENCES
PE Ratio Performance Analysis for ERIS LIFESCIENCES
- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 22.52x.
- ERIS LIFESCIENCES 's operated at median p/e ratio of 23.06x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2024 at 29.19x.
- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2020 of 16.88x.
How does ERIS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ERIS LIFESCIENCES | 352.33 | 57.04 | 20,097.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.55 | 419,764.0 |
CIPLA LTD | 5,000.43 | 23.78 | 118,905.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 19.07 | 103,523.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 21.78 | 100,015.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 78.86 | 163,010.0 |
MANKIND PHARMA LTD | 2,050.73 | 50.67 | 103,904.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 59.24 | 110,313.0 |
LUPIN LTD | 2,651.94 | 37.86 | 100,405.0 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.77 | 69,214.1 |
ABBOTT INDIA LTD | 1,334.46 | 47.45 | 63,315.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ERIS LIFESCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.07x |
Max industry PE | 78.86x |
Median industry PE | 37.86x |
Average industry PE | 41.10x |
You may also like the below Video Courses